Est. 1995 - Beverly Hills, California ~40% of the U.S. kombucha market 100,000,000+ bottles sold a year 100% founder-owned - zero outside funding 2026: first-ever canned kombucha ships Still small-batch fermented, still unpasteurized Est. 1995 - Beverly Hills, California ~40% of the U.S. kombucha market 100,000,000+ bottles sold a year 100% founder-owned - zero outside funding 2026: first-ever canned kombucha ships Still small-batch fermented, still unpasteurized

Company Profile  /  Consumer & Wellness

The kombucha company that never sold, and the teenager who brewed it

GT Dave started bottling fermented tea in his parents' kitchen as a teenager. Three decades later he owns 100% of the company that created America's kombucha aisle - and has turned down every buyer who came knocking.

Walk into almost any American grocery store and there is a refrigerated wall of kombucha - fizzy, faintly vinegary, sold in glass bottles with hand-lettered labels. Thirty years ago that wall did not exist. The reason it does is a company in Beverly Hills called GT's Living Foods, and a founder, GT Dave, who started bottling the stuff in his family's kitchen before he could legally sign a lease.

The short version is well documented and unusually literal: in the early 1990s the Dave family kept a fermenting jar of kombucha going from a starter culture, a rubbery disc of yeast and bacteria known as a SCOBY. When GT's mother, Laraine, was diagnosed with breast cancer in 1994, she credited the daily tea as part of her routine through treatment. Her teenage son decided other people should be able to buy it. In 1995 he bottled a batch by hand and sold two cases to a Los Angeles health-food store. That was the entire American kombucha industry, on day one.

GT Dave was around 15 when he started, and dropped out of high school to give the business his full attention. The name is the plainest branding decision imaginable - the company is called GT's because those are his initials. Within a year he had moved from the family kitchen to a small rented commercial space and was delivering cases to natural-food stores across Los Angeles by hand. There was no template to copy; kombucha was an obscure home remedy, and every account started as a conversation about what the cloudy, fizzing bottle actually was. That teaching burden shaped the company's early culture as much as any recipe did.

What it doesIt ferments living food, at national scale

GT's makes fermented, probiotic-rich food and drink and sells it through grocery. The flagship is kombucha - sweetened tea fermented with a culture until it turns lightly sour, fizzy and alive with microbes. GT's keeps its version raw and unpasteurized, which is both a marketing position and a logistics headache: the product has to stay cold from the brewery to the shelf. The company frames the whole enterprise in a single line it has used for years - "handcrafting living food for the living body since 1995."

Around that core sit a set of adjacent living-foods products: COCOYO, a dairy-free coconut yogurt; AGUA DE KEFIR, a cultured water kefir; and ALIVE, an adaptogenic elixir line. In early 2026 the company did something it had avoided for three decades and put kombucha in an aluminum can, launching SYNERGY Enlightened in a lighter, fiber-added format aimed squarely at shoppers watching sugar and, increasingly, taking GLP-1 medications.

1995First bottle sold
~40%U.S. kombucha share
100M+Bottles per year

Who buys itShoppers who wanted the aisle they now shop

The customer is a health-conscious grocery shopper, and the scale is national. GT's products reach shoppers through natural grocers and mass retail - Whole Foods, Target, Costco, Sprouts - plus direct-to-consumer e-commerce, across tens of thousands of retail doors in North America and Europe. The company reports selling more than 100 million bottles a year. What is notable is that GT's largely created its own demand: the first buyers had to be taught what kombucha even was, often by Laraine Dave herself, who worked in-store tasting tables as the company's first employee and told her own recovery story to strangers deciding whether to try a sample.

The customer base widened as the category did. What began with natural-foods devotees now includes mainstream grocery shoppers who first met kombucha at a Target or Costco cooler. The 2026 canned line is aimed at a newer slice of that audience - people managing sugar and appetite, including those on GLP-1 medications - who want the functional benefits in a lighter, more portable format than a cold glass bottle. It is the same drink, repositioned for a customer who did not exist when the first bottle sold.

"I started this company as a teenager with no business plan, no investors - just a belief in the power of living foods." GT Dave, Founder & CEO

The problem it solvesAccess to something that used to be homemade

Before 1995, kombucha in the United States was a folk practice - something you brewed in a jar on the counter if a friend gave you a culture, with all the inconsistency and risk that implies. GT's turned a home ferment into a standardized, safety-controlled, shelf-ready product. That is the practical problem it solved: it made a living, perishable food reliable enough to distribute nationally without losing the qualities - raw, unpasteurized, culture-forward - that made people want it in the first place. Fermenting at that scale while keeping the product genuinely alive is the hard part, and it is most of the business.

Abstract Swiss-style graphic of circles, arcs and bars in the GT's palette
The culture, abstracted. A SCOBY is a living disc of yeast and bacteria; here it becomes a Swiss-poster circle, rings of fermentation spinning off it. Everything GT's sells starts as a version of this.

How it's differentEveryone else took the money

The competitive set is now crowded and well-capitalized. Health-Ade drew investment tied to Coca-Cola's orbit. KeVita is owned outright by PepsiCo. Brew Dr., Humm and Remedy all compete for cold-shelf space. GT's difference is structural rather than a flavor or a slogan: it is still privately held and, by the founder's account, has never taken a dollar of outside funding. GT Dave owns the whole thing and has turned down repeated acquisition offers. That independence lets the company keep decisions - like refusing to pasteurize, or killing a product line - entirely in-house.

Category context
U.S. / global kombucha market, approximate size by year (USD, industry estimates)
2024 '26 '27 '28 2029 $2.4B ~$6B

The tailwind is real: the kombucha category is projected to grow at a double-digit annual clip and roughly double over the decade. GT's spent thirty years building the shelf that everyone else now wants to stock.

Products & servicesOne culture, several formats

The lineup reads as a series of bets on the same idea - live cultures, different vehicles:

Portfolio
Where GT's has pointed its fermentation, by launch era
SYNERGY
1995
CLASSIC
1995
COCOYO
2016
ALIVE
2019
ADK Kefir
2020
SYN Cans
2026

Not every bet stays. In 2018 GT's launched Dream Catcher, a CBD-infused sparkling water, and discontinued it in 2021 as the regulatory picture stayed murky. The willingness to shut a line down is part of the operating style - and easier to do when there is no outside board to answer to.

Business modelWholesale beverages, kept private

Mechanically, GT's is a consumer packaged goods manufacturer: it ferments and bottles its own products and sells them, mostly wholesale, into retail, with a growing direct e-commerce channel. Revenue comes from volume across that retail footprint. Forbes has cited annual sales around $275 million; third-party databases estimate figures in the low hundreds of millions. What is not in dispute is the ownership structure - the company took no venture money and remains founder-owned, which is rare for a CPG brand of this size.

"To this day, I have not accepted any outside funding and turned down numerous acquisition offers to continue to maintain sole ownership of the company." GT Dave

ExpertiseFermentation, held as a craft

The company's core competence is running live fermentation reliably and at scale - the same heirloom culture line, small-batch methods, and cold-chain discipline, stretched across a national supply chain. It is a genuinely hard operational skill, because the product keeps changing on its own until you stop it. GT Dave has leaned into a hands-on version of this: he has said he drinks a large amount of kombucha daily and still taste-tests batches personally, often on the factory floor. That founder attention functions as a quality-control layer, not just a story.

Where it fitsThe independent at the center of the category

In market terms, GT's sits at the center of a category it invented and still leads, holding an estimated 40% of U.S. kombucha while surrounded by rivals backed by the largest beverage companies in the world. In 2025 it named Jon Clancy as its first-ever President, a sign of an operation professionalizing as it scales, with GT Dave staying on as Founder and CEO. The 2026 move into cans reads as the next chapter: taking a refrigerated, glass-bottle craft product toward a broader, more convenient shelf without giving up the live cultures that define it.

$0Outside funding raised
2016First acquisition (CocoYo)
2026First canned kombucha

The through-line across thirty years is consistency of ownership and process. GT's kept the same culture, the same refusal to pasteurize, and the same single owner while the world caught up to the drink. That is an unusual combination in modern consumer goods, and it is most of what makes the company worth understanding.

#kombucha#gt-dave#synergy-kombucha#probiotics #gut-health#fermented-tea#living-foods#functional-beverages #family-owned#beverly-hills#cpg#wellness